FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported results for its first quarter ended March 31, 2007. For the quarter ended March 31, 2007, NovaDel reported a net loss of $5.4 million, or $0.09 cents per share, compared to a net loss of $2.1 million, or $0.05 cents per share, for the quarter ended April 30, 2006. NovaDel recently changed its fiscal year end from July 31 to December 31, effective December 31, 2006.
